RLDatix Life Sciences is proud to recognize the significant contributions of John Patrick Oroho, JD, as he announces his retirement. John will remain with the company in an advisory role throughout the coming year.
John founded Porzio Life Sciences in 2004, building a company renowned for its leadership in life sciences compliance and regulatory consulting. Under his guidance, Porzio developed a reputation for excellence, eventually becoming part of RLDatix in 2022. As President and General Manager of RLDatix Life Sciences, John’s forward-thinking leadership shaped the business into what it is today.
Throughout his career, John has played a pivotal role in driving compliance standards in the pharmaceutical industry. His expertise in areas like Aggregate Spend, the Physician Payment Sunshine Act, and the Prescription Drug Marketing Act, among others, has been instrumental in helping companies navigate increasingly complex regulatory landscapes. His work has left a lasting impact on the field, setting benchmarks that will continue to influence the industry.
John’s influence extends beyond his professional achievements. He is known for his dedication to mentoring colleagues and his commitment to fostering leadership within the industry. As he steps into retirement, we celebrate not just his professional legacy but also the relationships he has built along the way.
We at RLDatix and RLDatix Life Sciences extend our deepest gratitude to John for his visionary leadership and dedication over the years and wish him all the best in his retirement.